Skip to Content


In the US, Succimer (succimer systemic) is a member of the drug class chelating agents and is used to treat Lead Poisoning, Severe.

US matches:



CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Antidote: Chelating agent

Diagnostic agent

Chemical Name

Butanedioic acid, 2,3-dimercapto-

Foreign Names

  • Succimerum (Latin)
  • Succimer (German)
  • Succimer (French)
  • Succimero (Spanish)

Generic Names

  • Succimer (OS: DCF, USAN, BAN)
  • DIM-SA (IS: MediPhysics)
  • DMSA (IS)
  • Suximer (IS)

Brand Names

  • Chemet
    Recordati Rare Diseases, United States; Sanofi-Synthelabo, United States
  • Dimersu
    UBI, Taiwan
  • DMSA
    BIOMEDIS, Slovenia; Izotóp Intézet, Hungary
  • Renocis
    CIS bio International, France
  • Succicaptal
    IFET, Greece; SERB Laboratoires, France
  • TechneScan DMSA
    Mallinckrodt, Malta; Mallinckrodt Deutschland, Poland


BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.